CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), announced today that it has signed a national agreement with UnitedHealthcare ...
C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is ...
Alzheimer’s is usually tied to older age, but a new case spotlights a 19-year-old young man with a pattern that resembles the ...
The 2024 McDonald criteria, published just before the 2025 ECTRIMS Congress, substantially expand criteria for a probable diagnosis of multiple sclerosis, experts report.
Certification critical to broad U.S. market release of the CNSide CSF Assay PlatformCNSide now meets key federal and state regulatory ...
A new clinical trial published in the New England Journal of Medicine found that among patients with idiopathic ...
Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by ...
The gene therapy company uniQure has announced top-level data from its trial of AMT-130, a new gene therapy designed to treat ...
Daijiworld Media Network - Thiruvananthapuram Thiruvananthapuram, Sep 14: An 18-year-old patient undergoing treatment at the ...
13don MSN
Hospital patient died from side effects of medicine prescribed for an infection she didn't have
Audrey Newman wasn't tested after being admitted to Stepping Hill Hospital due to a 'lack of competent ward doctors' ...
Biogen expands its drug delivery solutions by acquiring Alcyone Therapeutics, enhancing patient-centered therapies with the ...
Audrey Newman, who had suffered a seizure at home, was admitted to Stepping Hill Hospital in Stockport - where she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback